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A B S T R A C T
The report presents two cases of neurofibromatosis type 1 one previously known and one detected during pregnancy. It
describes how the disease was detected and diagnosed, and what was the outcome of pregnancies. This is the first case of
prenatal neurofibromatosis type 1 diagnosed in our clinic.
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Introduction
Neurofibromatosis type 1 (NF1) is one of the most
common genetic disorders with an incidence of 1 in 3,500
live births. It is an autosomal dominant condition with a
wide range of clinical manifestations. There are at least
250 unique NF1 mutations reported so far. Specific pre-
natal diagnosis is only possible through an indirect link-
age analysis in families with a previously identified mu-
tation. To date, only limited information is available on
pregnancy in women with NF1, but current obstetrical
literature indicates that this group of women has in-
creased complications associated with pregnancy.
Case Reports
The patient was a nulliparous, 32-year-old woman
who was referred to our Prenatal Care Unit to confirm
intrauterine growth restriction. Clinical history and phy-
sical examination did not reveal any relevant informa-
tion. The first ultrasound was made in our Outpatient
Sonography Unit at 25 weeks of gestation, when the di-
agnosis of NF1 was made.
She was admitted to our Clinic at 33 weeks of gestati-
on, after a physical examination that showed inappropriate
distance from uterine fundus to symphysis. Ultrasound
examination confirmed intrauterine growth retardation
(IUGR) diagnosis. NF1 was suspected when the obstetri-
cian saw café-au-lait spots and multiple fibromas all over
her body. From her family history it is important to men-
tion that her mother passed away from brain tumor, aris-
ing suspicion of brain malignancy as a form of genetic
disease. She was a single child, and could not provide any
information on other family members that we could link
with clinical symptoms and signs of a disease.
The patient herself was never seriously ill, save for al-
lergic reaction to penicillin. Her intellectual capabilities
were below average, what can be interpreted as a sign of
a disease. She underwent dermatological, ophthalmo-
logic, head and neck examinations, as well as a CT scan
of the brain. Dermatological examination showed multi-
ple café-au-lait spots and all over her body, with the big-
gest one on the back of her neck. Multiple fibromas were
also spread all over the body, with the most visible
change on the left side of her abdomen. Other examina-
tion results were normal.
In addition to IUGR the ultrasound of the fetus,
showed oligohydramnios. It is the case when the volume
of amniotic fluid is far below the normal limits and it can
occasionally be reduced to only a few mL of viscid fluid.
Oligohydramnios is usually associated with adverse con-
ditions of the fetus, mother, or placenta.
Color Doppler showed increased resistance index (RI)
of umbilical cord artery and medial cerebral artery (ACM).
After administering 1x12 mg of dexamethason for two
days, the pregnancy was terminated by cesarean section
in the gestational age of 34 weeks. A 1400/41 neonate
was born, Apgar score 6 / 6 / 7. A neonate was immedi-
ately admitted in the Neonate Intensive Care Unit.
Other patient was a 24-year-old nulliparous woman
affected by NF1 and with a known familial history of a
disease. Her younger sister and father had heavy clinical
symptoms of NF1. The older sister, two sons and her
mother, who died of breast cancer had no signs of the dis-
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ease. The whole family underwent genetically testing,
which showed that beside her younger sister and the fa-
ther, our patient was also affected by NF1. She had but a
few café-au-lait spots on her body, but had ophthal-
mologic lesions and a change on the optical nerve which
is likely to be optic glioma. She underwent genetic coun-
seling and opted for prenatal testing, although prenatal
diagnosis can only identify whether a fetus will develop
NF1, and not whether serious complications will occur.
Amniocentesis was performed at 16 weeks of gestation
and total DNA was directly extracted from the sample.
Blood samples of all family members and the husband
were collected and linkage analysis was carried out.
Karyotipic analysis of all blood samples and fetal origin
(cell culture from amniotic fluid) was performed via poly-
morphic markers of gene NF1 (exon 5 Rsal polymor-
phism, IVS38GT53.0, IVS27AC28.4 and Alu polymor-
phism of intron 27). Genomic analysis has identified the
same haplotype from four samples (father, two sisters
and fetus), which is enough to make the diagnosis of
NF1. After finding out about the results, our patient de-
cided to have an abortion, which was induced by pros-
taglandins at 20 weeks of gestation.
Discussion
Neurofibromatosis type 1 (NF1, peripheral neuro-
fibromatosis, von Recklinghausen disease) is one of the
most common genetic disorders occurring once in every
4,000 births. It is an autosomal dominant condition
which has markedly variable clinical expressions, with
manifestations ranging from mild cutaneous lesions like
café-au-lait spots and axillary freckling to plexiform
neurofibromas, optic gliomas, bony abnormalities, pse-
udoarthrosis and malignancies1. Some people with NF1
also have other manifestations, such as learning disabil-
ity and macrocephaly. About two thirds of the people who
have NF1 type inherit the disease from one of the par-
ents and the risk for each child is estimated to about
50%. The remaining third of the population develops this
condition due to spontaneous mutation. It seems that
most of the NF1 mutations reported so far (at least 250)
are unique.
Neurofibromatosis type 2 (NF2, central neurofibro-
matosis) is characterized by bilateral vestibular schwan-
nomas. NF2 is also an autosomal dominant disorder with
an incidence of 1 in 40, 000 persons. As their very differ-
ent clinical manifestations suggest, NF1 and NF2 are
caused by two entirely different genes2. The NF1 gene on
chromosome 17 codes for a huge protein named neuro-
fibromin, and was first cloned in 1990. Its function re-
mains unclear, although it does contain a single domain
with GTPase activating activity. The NF2 gene on chro-
mosome 22 was first cloned in 1993 and given the snazzy
name merlin. The exact function of merlin is also un-
known, but it is highly homologous to a family of cyto-
skeleton – associated proteins including moesin, ezrin,
radix and talin.
Many authors have suggested that pregnancy compli-
cations were more common in women with NF13. To
date, only limited information is available on pregnancy
in women with NF1. Published case reports point to an
association with intrauterine growth restriction, eclamp-
sia, oligohydramnios, stillbirth, pregnancy-induced hy-
pertension, preterm labor, spontaneous labor and growth
of neurofibromas with regression in size after delivery4.
With respect to NF1 changes during pregnancy, the ma-
jority of women report the development of new neuro-
fibromas, the growth of existing neurofibromas or both,
indicating that pregnancy may promote neurofibroma
growth. However, the reported initial appearance of neu-
rofibromas during pregnancy, regression of some neuro-
fibromas immediately after termination of pregnancy
and the presence of estrogen receptors in selected neu-
rofibromas in some women support the belief that this
growth is not purely coincidental4.
On the other hand, some authors suggest that the
only obstetrical complication they observed was some-
what more frequent cesarean section delivery.
Some recommend early termination of pregnancy and
sterilization of women because of the adverse effect of
the pregnancy on the course of the disease, poor preg-
nancy outcome and the possibility of transmission to the
fetus. This decision, however can only be made by the pa-
tient.
Whether she is either willing to continue or terminate
pregnancy, it is our obligation, as an obstetrical team to
help her in the best way possible. On the other hand, we
are also obliged to make as accurate prenatal diagnosis as
possible. Since the disease is causing mutations that are
dispersed throughout the gene, prenatal diagnosis usu-
ally relies on linkage analysis of family members and
rarely on direct characterization of the mutation. The ex-
treme variability of the phenotypic expression of the NF1
gene makes it very difficult for NF1 families to decide
whether to have children or not, as molecular diagnosis
cannot predict clinical expression of the disease5. The
psychological management of would-be parents is there-
fore very sensitive.
With these case reports, we wanted to describe the di-
agnostic possibilities, management of pregnancies and
dilemmas in every-day clinical practice of a gynecologist.
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NEUROFIBROMATOZA TIP 1 U TRUDNO]I
S A @ E T A K
Izlo`ili smo dva slu~aja neurofibromatoze tip 1 (NF1) u trudno}i, jedan je slu~aj neurofibromatoze poznat od ranije,
a drugi dijagnosticiran u trudno}i. Opisujemo dijagnostiku neurofibromatoze, na~in izvo|enja i mogu}nosti prenatalne
dijagnostike, kao i ishode ovih trudno}a. Ovo je prvi slu~aj prenatalno dijagnosticirane NF1 u na{oj Klinici.
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